Savvy Update 5/2/22: Ypsomed/Abbott/CamDiab, New Glucose & Ketone Monitoring, News from ATTD 2022, Luna for MDI, Pharmasens Combined Pump

Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes was announced by, on 27 April 2022.  

Ypsomed, Abbott, and CamDiab will work to accelerate the development of an automated insulin delivery system for people living with diabetes. The system is being designed to include Abbott’s FreeStyle Libre 3 sensor, CamDiab’s CamAPS FX algorithm, and Ypsomed’s mylife YpsoPump. The partnership demonstrates the companies’ collective desire to drive integrated solutions to help people with diabetes better manage their condition and improve health outcomes.

Leave a Reply

Your email address will not be published.